OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang, Christopher D. Hillyer, Lanying Du
Trends in Immunology (2020) Vol. 41, Iss. 5, pp. 355-359
Open Access | Times Cited: 913
Shibo Jiang, Christopher D. Hillyer, Lanying Du
Trends in Immunology (2020) Vol. 41, Iss. 5, pp. 355-359
Open Access | Times Cited: 913
Showing 26-50 of 913 citing articles:
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
Emanuele Andreano, Giulia Piccini, Danilo Licastro, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 36
Open Access | Times Cited: 359
Emanuele Andreano, Giulia Piccini, Danilo Licastro, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 36
Open Access | Times Cited: 359
T cell response to SARS-CoV-2 infection in humans: A systematic review
Madhumita Shrotri, May C I van Schalkwyk, Nathan Post, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245532-e0245532
Open Access | Times Cited: 351
Madhumita Shrotri, May C I van Schalkwyk, Nathan Post, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245532-e0245532
Open Access | Times Cited: 351
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan, Marc Madou, Sourav Kalra, et al.
ACS Nano (2020) Vol. 14, Iss. 7, pp. 7760-7782
Open Access | Times Cited: 347
Gaurav Chauhan, Marc Madou, Sourav Kalra, et al.
ACS Nano (2020) Vol. 14, Iss. 7, pp. 7760-7782
Open Access | Times Cited: 347
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung, Melissa N. Thone, Young Jik Kwon
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 1-25
Open Access | Times Cited: 347
Jee Young Chung, Melissa N. Thone, Young Jik Kwon
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 1-25
Open Access | Times Cited: 347
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Nathan Post, Danielle Eddy, Catherine Huntley, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0244126-e0244126
Open Access | Times Cited: 341
Nathan Post, Danielle Eddy, Catherine Huntley, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0244126-e0244126
Open Access | Times Cited: 341
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
Angkana T. Huang, Bernardo García‐Carreras, Matt D. T. Hitchings, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 336
Angkana T. Huang, Bernardo García‐Carreras, Matt D. T. Hitchings, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 336
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 335
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 335
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 10, pp. 1174-1183
Open Access | Times Cited: 283
Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 10, pp. 1174-1183
Open Access | Times Cited: 283
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Xiancai Ma, Fan Zou, Fei Yu, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1315-1330.e9
Open Access | Times Cited: 279
Xiancai Ma, Fan Zou, Fei Yu, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1315-1330.e9
Open Access | Times Cited: 279
SARS-CoV-2 escapein vitrofrom a highly neutralizing COVID-19 convalescent plasma
Emanuele Andreano, Giulia Piccini, Danilo Licastro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 277
Emanuele Andreano, Giulia Piccini, Danilo Licastro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 277
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
Lea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275
Lea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275
Test performance evaluation of SARS-CoV-2 serological assays
Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 245
Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 245
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Abdul Aleem, Abdul Samad, Amy Slenker
(2021) Vol. 01, pp. 01-01
Closed Access | Times Cited: 242
Abdul Aleem, Abdul Samad, Amy Slenker
(2021) Vol. 01, pp. 01-01
Closed Access | Times Cited: 242
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Kening Li, Bin Huang, Min Wu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 240
Kening Li, Bin Huang, Min Wu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 240
A simple protein-based surrogate neutralization assay for SARS-CoV-2
Kento T. Abe, Zhijie Li, Reuben Samson, et al.
JCI Insight (2020) Vol. 5, Iss. 19
Open Access | Times Cited: 224
Kento T. Abe, Zhijie Li, Reuben Samson, et al.
JCI Insight (2020) Vol. 5, Iss. 19
Open Access | Times Cited: 224
COVID-19 Antibody Tests and Their Limitations
Guoqiang Liu, James F. Rusling
ACS Sensors (2021) Vol. 6, Iss. 3, pp. 593-612
Closed Access | Times Cited: 198
Guoqiang Liu, James F. Rusling
ACS Sensors (2021) Vol. 6, Iss. 3, pp. 593-612
Closed Access | Times Cited: 198
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 635
Open Access | Times Cited: 191
Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 635
Open Access | Times Cited: 191
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
Mary Kathryn Bohn, Giuseppe Lippi, Andrea R. Horvath, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 58, Iss. 7, pp. 1037-1052
Open Access | Times Cited: 185
Mary Kathryn Bohn, Giuseppe Lippi, Andrea R. Horvath, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 58, Iss. 7, pp. 1037-1052
Open Access | Times Cited: 185
COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms
Peijie Zhong, Jing Xu, Dong Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 185
Peijie Zhong, Jing Xu, Dong Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 185
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020)
Kimberly E. Hanson, Angela M. Caliendo, Cesar Andres Diaz Arias, et al.
Clinical Infectious Diseases (2020) Vol. 78, Iss. 7, pp. e150-e169
Open Access | Times Cited: 182
Kimberly E. Hanson, Angela M. Caliendo, Cesar Andres Diaz Arias, et al.
Clinical Infectious Diseases (2020) Vol. 78, Iss. 7, pp. e150-e169
Open Access | Times Cited: 182
Medicinal Plants as Sources of Active Molecules Against COVID-19
Bachir Benarba, Atanasio Pandiella
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 180
Bachir Benarba, Atanasio Pandiella
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 180
SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights
Swapnil B. Kadam, Geetika S. Sukhramani, Pratibha Bishnoi, et al.
Journal of Basic Microbiology (2021) Vol. 61, Iss. 3, pp. 180-202
Open Access | Times Cited: 170
Swapnil B. Kadam, Geetika S. Sukhramani, Pratibha Bishnoi, et al.
Journal of Basic Microbiology (2021) Vol. 61, Iss. 3, pp. 180-202
Open Access | Times Cited: 170
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
Peter Muench, Simon Jochum, Verena Wenderoth, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 10
Open Access | Times Cited: 168
Peter Muench, Simon Jochum, Verena Wenderoth, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 10
Open Access | Times Cited: 168
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 166
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 166
Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19
Atanu Acharya, Rupesh Agarwal, Matthew Baker, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 12, pp. 5832-5852
Open Access | Times Cited: 165
Atanu Acharya, Rupesh Agarwal, Matthew Baker, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 12, pp. 5832-5852
Open Access | Times Cited: 165
